Article Listing - Unprecedented survival results for B-MS Yervoy and Roche’s vemurafenib in melanoma discussed at ASCO

H PYLORI TREATMENT: A ROLE FOR OMEPRAZOLE?

25 May 1992

In the light of new data from studies investigating triple therapy-based eradication of the bacterium Helico-bacter pylori (Marketletter May 11)...

LEON GAUCI JOINS CORTECS

25 May 1992

- Cortecs Ltd, the UK-based innovative drug delivery systems specialist, has appointed Leon Gauci as executive vice president of the...

PROCTER & GAMBLE'S WOLFGANG BERNDT

25 May 1992

- Wolfgang Berndt becomes president, health and beauty-care products at Procter & Gamble Europe on June 30, on the retirement...

VITAMIN K1 /CANCER LINK INVESTIGATED

25 May 1992

Claims that intramuscular injections of vitamin K1 can cause cancer are under investigation by the UK Department of Health. Such...

STOCK MARKET COMMENTARY: NEW YORK

25 May 1992

NEW YORK: set an all-time high at the close of the last reporting period, just short of the 3,400 level,...

SERAGEN EXPANDS IL-2 STUDIES

25 May 1992

US biotechnology concern Seragen has expanded clinical studies with its recombinant interleukin-2 product, which is in development as a treatment...

PRECLINICAL RESULTS WITH TLC C-53

25 May 1992

As reported briefly in the Market-letter last week, The Liposome Company now has preclinical data available on its liposome-encapsulated prostaglandin...

EC PHARMA COMMITTEE MEETING

25 May 1992

At its meeting on May 12-13, the Commission of the European Communities' Committee for Proprietary Medicinal Products adopted 12 multi-state...

TOUGH NEW GERMAN SPENDING CONTROLS

25 May 1992

The new German Health Minister, Horst Seehofer, is planning tough new measures to restrict health care spending by the public-sector...

MORATORIUM ON NEW US REGS

25 May 1992

The US Food and Drug Administ-ration seems to be unconcerned by an Administration decision to extend by 90 days a...

Showing 94041-94050 of 95558 articles